SMAIO is a manufacturer of implantable medical devices for the treatment of spinal pathologies.
SMAIO has raised $2.3M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2026.
SMAIO's investors include Bpifrance, BNP Paribas, Societe Generale S.A., European Union, NextStage AM.
SMAIO is headquartered in Saint Priest, France.
SMAIO is a manufacturer of implantable medical devices for the treatment of spinal pathologies.
SMAIO is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SMAIO — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/smaio. Accessed July 20, 2026.
VCBacked. (2026). SMAIO — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/smaio
{{cite web |title=SMAIO — Funding & Investors |url=https://www.vcbacked.co/company/smaio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated